214 related articles for article (PubMed ID: 18077705)
1. Role of APOBEC3G/F-mediated hypermutation in the control of human immunodeficiency virus type 1 in elite suppressors.
Gandhi SK; Siliciano JD; Bailey JR; Siliciano RF; Blankson JN
J Virol; 2008 Mar; 82(6):3125-30. PubMed ID: 18077705
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
3. [Antiviral defense by APOBEC3 family proteins].
Takaori A
Uirusu; 2005 Dec; 55(2):267-72. PubMed ID: 16557012
[TBL] [Abstract][Full Text] [Related]
4. Contribution of APOBEC3G/F activity to the development of low-abundance drug-resistant human immunodeficiency virus type 1 variants.
Noguera-Julian M; Cozzi-Lepri A; Di Giallonardo F; Schuurman R; Däumer M; Aitken S; Ceccherini-Silberstein F; D'Arminio Monforte A; Geretti AM; Booth CL; Kaiser R; Michalik C; Jansen K; Masquelier B; Bellecave P; Kouyos RD; Castro E; Furrer H; Schultze A; Günthard HF; Brun-Vezinet F; Metzner KJ; Paredes R;
Clin Microbiol Infect; 2016 Feb; 22(2):191-200. PubMed ID: 26482266
[TBL] [Abstract][Full Text] [Related]
5. Human APOBEC3G-mediated hypermutation is associated with antiretroviral therapy failure in HIV-1 subtype C-infected individuals.
Neogi U; Shet A; Sahoo PN; Bontell I; Ekstrand ML; Banerjea AC; Sonnerborg A
J Int AIDS Soc; 2013 Feb; 16(1):18472. PubMed ID: 23443042
[TBL] [Abstract][Full Text] [Related]
6. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
[TBL] [Abstract][Full Text] [Related]
7. Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.
Romani B; Engelbrecht S; Glashoff RH
Arch Virol; 2009; 154(10):1579-88. PubMed ID: 19669862
[TBL] [Abstract][Full Text] [Related]
8. APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count.
Cho SJ; Drechsler H; Burke RC; Arens MQ; Powderly W; Davidson NO
J Virol; 2006 Feb; 80(4):2069-72. PubMed ID: 16439564
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus (HIV) type 1 proviral hypermutation correlates with CD4 count in HIV-infected women from Kenya.
Land AM; Ball TB; Luo M; Pilon R; Sandstrom P; Embree JE; Wachihi C; Kimani J; Plummer FA
J Virol; 2008 Aug; 82(16):8172-82. PubMed ID: 18550667
[TBL] [Abstract][Full Text] [Related]
10. An Alu Element Insertion in Intron 1 Results in Aberrant Alternative Splicing of APOBEC3G Pre-mRNA in Northern Pig-Tailed Macaques (
Zhang XL; Luo MT; Song JH; Pang W; Zheng YT
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776266
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
12. Quantification of deaminase activity-dependent and -independent restriction of HIV-1 replication mediated by APOBEC3F and APOBEC3G through experimental-mathematical investigation.
Kobayashi T; Koizumi Y; Takeuchi JS; Misawa N; Kimura Y; Morita S; Aihara K; Koyanagi Y; Iwami S; Sato K
J Virol; 2014 May; 88(10):5881-7. PubMed ID: 24623435
[TBL] [Abstract][Full Text] [Related]
13. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz.
Covino DA; Purificato C; Catapano L; Galluzzo CM; Gauzzi MC; Vella S; Lefebvre E; Seyedkazemi S; Andreotti M; Fantuzzi L
Front Immunol; 2018; 9():1839. PubMed ID: 30135687
[TBL] [Abstract][Full Text] [Related]
15. [Mechanisms for inhibition of retrovirus replication by APOBEC3 family].
Iwatani Y
Uirusu; 2011 Jun; 61(1):67-72. PubMed ID: 21972557
[TBL] [Abstract][Full Text] [Related]
16. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
[TBL] [Abstract][Full Text] [Related]
17. Different interaction between HIV-1 Vif and its cellular target proteins APOBEC3G/APOBEC3F.
Nagao T; Yamashita T; Miyake A; Uchiyama T; Nomaguchi M; Adachi A
J Med Invest; 2010 Feb; 57(1-2):89-94. PubMed ID: 20299747
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates.
Zennou V; Bieniasz PD
Virology; 2006 May; 349(1):31-40. PubMed ID: 16460778
[TBL] [Abstract][Full Text] [Related]
19. [APOBEC3 hypermutations in HIV-1 infected cases in Turkey].
Sayan M; Simşek F; Ceran N; Dokuzoğuz B; Eraksoy H
Mikrobiyol Bul; 2013 Jul; 47(3):482-92. PubMed ID: 23971925
[TBL] [Abstract][Full Text] [Related]
20. APOBEC-mediated interference with hepadnavirus production.
Rösler C; Köck J; Kann M; Malim MH; Blum HE; Baumert TF; von Weizsäcker F
Hepatology; 2005 Aug; 42(2):301-9. PubMed ID: 16025511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
